246 related articles for article (PubMed ID: 3746133)
1. Contraceptive steroids increase hepatic uptake of chylomicron remnants in healthy young women.
Berr F; Eckel RH; Kern F
J Lipid Res; 1986 Jun; 27(6):645-51. PubMed ID: 3746133
[TBL] [Abstract][Full Text] [Related]
2. Effects of estrogen/progestin agents on plasma retinoids and chylomicron remnant metabolism.
Gleeson JM; Dukes CS; Elstad NL; Chan IF; Wilson DE
Contraception; 1987 Jan; 35(1):69-78. PubMed ID: 3568661
[TBL] [Abstract][Full Text] [Related]
3. Plasma decay of chylomicron remnants is not affected by heparin-stimulated plasma lipolytic activity in normal fasting man.
Berr F; Eckel R; Kern F
J Lipid Res; 1985 Jul; 26(7):852-9. PubMed ID: 4031663
[TBL] [Abstract][Full Text] [Related]
4. Plasma clearance of chylomicrons labeled with retinyl palmitate in healthy human subjects.
Berr F; Kern F
J Lipid Res; 1984 Aug; 25(8):805-12. PubMed ID: 6491526
[TBL] [Abstract][Full Text] [Related]
5. Characterization of chylomicron remnant clearance by retinyl palmitate label in normal humans.
Berr F
J Lipid Res; 1992 Jun; 33(6):915-30. PubMed ID: 1512515
[TBL] [Abstract][Full Text] [Related]
6. Contraceptive steroids increase cholesterol in bile: mechanisms of action.
Kern F; Everson GT
J Lipid Res; 1987 Jul; 28(7):828-39. PubMed ID: 3625039
[TBL] [Abstract][Full Text] [Related]
7. Postprandial lipoprotein metabolism in normolipidemic men with and without coronary artery disease.
Groot PH; van Stiphout WA; Krauss XH; Jansen H; van Tol A; van Ramshorst E; Chin-On S; Hofman A; Cresswell SR; Havekes L
Arterioscler Thromb; 1991; 11(3):653-62. PubMed ID: 2029503
[TBL] [Abstract][Full Text] [Related]
8. Effects of three low-dose oral contraceptive formulations on lipid metabolism.
Bertolini S; Elicio N; Cordera R; Gapitanio GL; Montagna G; Croce S; Saturnino M; Balestreri R; De Cecco L
Acta Obstet Gynecol Scand; 1987; 66(4):327-32. PubMed ID: 2962417
[TBL] [Abstract][Full Text] [Related]
9. Comparative studies of the ethynyl estrogens used in oral contraceptives. VII. Effects with and without progestational agents on ultracentrifugally fractionated plasma lipoproteins in humans, baboons, and beagles.
Goldzieher JW; Chenault CB; de la Peña A; Dozier TS; Kraemer DC
Fertil Steril; 1978 Nov; 30(5):522-33. PubMed ID: 214353
[TBL] [Abstract][Full Text] [Related]
10. Delayed clearance of chylomicron remnants following vitamin-A-containing oral fat loads in broad-beta disease (type III hyperlipoproteinemia).
Hazzard WR; Bierman EL
Metabolism; 1976 Jul; 25(7):777-801. PubMed ID: 181657
[TBL] [Abstract][Full Text] [Related]
11. Progestins and oral contraceptive-induced lipoprotein changes: a prospective study.
Lipson A; Stoy DB; LaRosa JC; Muesing RA; Cleary PA; Miller VT; Gilbert PR; Stadel B
Contraception; 1986 Aug; 34(2):121-34. PubMed ID: 3096633
[TBL] [Abstract][Full Text] [Related]
12. Kinetics of chylomicron remnant clearance in normal and in hyperlipoproteinemic subjects.
Cortner JA; Coates PM; Le NA; Cryer DR; Ragni MC; Faulkner A; Langer T
J Lipid Res; 1987 Feb; 28(2):195-206. PubMed ID: 3572247
[TBL] [Abstract][Full Text] [Related]
13. Simvastatin improves chylomicron remnant removal in familial combined hyperlipidemia without changing chylomicron conversion.
Cabezas MC; de Bruin TW; Kock LA; Kortlandt W; Van Linde-Sibenius Trip M; Jansen H; Erkelens DW
Metabolism; 1993 Apr; 42(4):497-503. PubMed ID: 8487674
[TBL] [Abstract][Full Text] [Related]
14. Lipids, cardiovascular disease, and oral contraceptives: a practical perspective.
Upton GV
Fertil Steril; 1990 Jan; 53(1):1-12. PubMed ID: 2403935
[TBL] [Abstract][Full Text] [Related]
15. Chylomicron/chylomicron remnant turnover in humans: evidence for margination of chylomicrons and poor conversion of larger to smaller chylomicron remnants.
Karpe F; Olivecrona T; Hamsten A; Hultin M
J Lipid Res; 1997 May; 38(5):949-61. PubMed ID: 9186912
[TBL] [Abstract][Full Text] [Related]
16. Lipoprotein lipase enhances removal of chylomicrons and chylomicron remnants by the perfused rat liver.
Skottova N; Savonen R; Lookene A; Hultin M; Olivecrona G
J Lipid Res; 1995 Jun; 36(6):1334-44. PubMed ID: 7666010
[TBL] [Abstract][Full Text] [Related]
17. A frequently occurring mutation in the lipoprotein lipase gene (Asn291Ser) results in altered postprandial chylomicron triglyceride and retinyl palmitate response in normolipidemic carriers.
Pimstone SN; Clee SM; Gagné SE; Miao L; Zhang H; Stein EA; Hayden MR
J Lipid Res; 1996 Aug; 37(8):1675-84. PubMed ID: 8864951
[TBL] [Abstract][Full Text] [Related]
18. Postprandial dyslipidemia in men with visceral obesity: an effect of reduced LDL receptor expression?
Mamo JC; Watts GF; Barrett PH; Smith D; James AP; Pal S
Am J Physiol Endocrinol Metab; 2001 Sep; 281(3):E626-32. PubMed ID: 11500319
[TBL] [Abstract][Full Text] [Related]
19. Relationship between improved postprandial lipemia and low-density lipoprotein metabolism during treatment with tetrahydrolipstatin, a pancreatic lipase inhibitor.
Reitsma JB; Castro Cabezas M; de Bruin TW; Erkelens DW
Metabolism; 1994 Mar; 43(3):293-8. PubMed ID: 8139476
[TBL] [Abstract][Full Text] [Related]
20. Desogestrel- and levonorgestrel-containing oral contraceptives have different effects on urinary excretion of prostacyclin metabolites and serum high density lipoproteins.
Ylikorkala O; Kuusi T; Tikkanen MJ; Viinikka L
J Clin Endocrinol Metab; 1987 Dec; 65(6):1238-42. PubMed ID: 2960690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
